NOVOPLEX

 

StockNo	Product description
EB0280-418-11	NOVOPLEX AMPOULE 5 ML
EB0280-418-32	NOVOPLEX AMPOULE 2 ML

 

COMPOSITION:
3.42 % solution of equimolecular complex of procaine hydrochloride and caffeine.
100 ml of isotonic solution contains 2 g procaine and 1.42 g caffeine (calculated as a base).

ACTION:
A combined preparation with well manifested local analgesic effect. The procaine contained in it exercises a short-lived analgesic, antiphlogistic, antishock and spasmolytic action. As a central analeptic, caffeine potentiates the analgesic action of procaine and contributes to dilation of the blood vessels of the heart, kidneys, skin, skeletal, muscles and lungs.
Novoplex is distinguished by its low toxicity and good tolerance after parenteral application.

INDICATIONS:
Arthritis, arthrosis, tendovaginitis, bursitis, pleural pains, herpes zoster, angiospasms, gangrene, thrombangitis, Burger's diseases, ischias, lumbago, otitis and migraine.

CONTRAINDICATIONS:
Hypersensitivity to some individual components of the preparation, myasthenia, treatment with sulfonamides and purulent processes at the place of application. The preparation should be applied cautiously in severe cardiac, liver and kidney diseases.

PRECAUTIONS:
Before application of Novoplex, it is necessary to examine the patient for increased sensitivity by epicutaneous or other tests.

DRUG INTERACTIONS:
Combined therapy of Novoplex with salicylates and sulfonamides decreases both the bacteriostatic and the anesthetic action of the separate ingrediants.

DOSAGE AND ADMINISTRATION:
Novoplex is applied parenterally - intramuscularly, subcutaneously and intravenously. In arthritis and arthrosis, the preparation is applied periarticularly and periostally, in angiospasms - paravasally in doses from 0.5 to 2 ml.

MEDICINAL FORM AND PACKAGE:
Ampoules of 2 ml and 5 ml in packs of 10 and 50.

STORAGE:
At moderate temperature (15-30° C).

EXPIRY:
3 (three) years.